August 8, 2022
Cocktail meds likely to be banned as soon as government starts final discussions

The Modi government is set to ban commonly sold cough syrups and drugs, including Piriton, Grilinctus, Sumo and De Cold Total, which are among the 19 fixed drug combinations (FDCs) under the scanner, as the government plans to To eliminate irrational combinations. has learned.

However, the health ministry is considering retaining some FDC-based cough syrups to prevent shortages.

In all, the Central Drugs Standard and Control Organization (CDSCO) has compiled a list of 19 FDCs, which were finalized by the Expert Committee constituted under the chairmanship of Dr. MS Bhatia, Professor and Head, Department of Psychiatry, University College of Medical Sciences was. ,

The list has now been submitted to the Ministry of Health and Family Welfare.

FDCs, or cocktail drugs, combine more than one drug in a single pill, and have increasingly come under the official lens because a combination of drugs, such as antibiotics, can result in drug resistance in the disease-causing organism. Is.

The list includes Sumo, Nicip, D Cold Total, Vicks Action 500 Advanced, cough syrup Tedykoff, Grilinctus, Codistar, Tossex, Ascoril C, Piriton Expectorant and antibiotic ointment clindamycin. Pharma companies manufacturing these drugs include Alkem, Cipla, Reckitt Benckiser, Procter & Gamble, Mankind Pharma, Abbott, Glenmark and GlaxoSmithKline.

“While the list of 19 FDCs is final, it includes a lot of cough syrups. If a ban is announced, it could wipe out a large segment from the market, leading to a shortage of branded cough syrups. Hence, we are reconsidering some FDCs,” said a government official in the ministry. “We are looking at maintaining two to three combinations and banning other products. For example: Tixylix Syrup and Corex may be continued.

The official said that since “these cocktail drugs are not found in any developed country, India will take a decision soon.”

Stakeholders under Bhatia Committee have submitted information on rationality, safety and efficacy with respect to the said FDCs.

The expert committee was constituted by the central government following the Supreme Court’s decision in 2017.

The government, in 2016, launched a campaign to filter many of these FDCs from the Indian pharmaceutical industry, banning nearly 350 of them, affecting more than 2,700 branded drugs.

read all breaking news And today’s fresh news Here

Leave a Reply

Your email address will not be published.